RecruitingPHASE1, PHASE2NCT05610735

Combination Therapy for Recurrent Ovarian Cancer

Studying Malignant epithelial tumor of ovary

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Sham Sunder Kakar
Principal Investigator
Whitney Goldsberry, MD
Brown Cancer Center at University of Louisville
Intervention
DOXIL(drug)
Enrollment
72 enrolled
Eligibility
18 years · FEMALE
Timeline
20242028

Study locations (1)

Collaborators

University of Louisville

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05610735 on ClinicalTrials.gov

Other trials for Malignant epithelial tumor of ovary

Additional recruiting or active studies for the same condition.

See all trials for Malignant epithelial tumor of ovary

← Back to all trials